Screening for sexually transmitted infections in substance abuse treatment programs

Jane M. Liebschutz, Erin Finley Garcia, Phillip G. Braslins, Demian Christiansen, Nicholas J. Horton, Jeffrey H. Samet

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objectives: We evaluated the prevalence of the sexually transmitted infections (STIs) chlamydia and gonorrhea in clients at a methadone maintenance program and a residential detoxification program. Methods: We collected urine specimens for chlamydia and gonorrhea ligase chain reaction testing and assessed sexual, substance abuse and STI histories. Results: Of 700 subject assessments, 490 occurred among detoxification clients and 210 in methadone maintenance. Chlamydia trachomatis was detected in 5/700 (0.9, 95% CI=0.1-1.8%) and Neisseria gonorrhoeae in none. All chlamydia infected subjects were recruited from the detoxification program. Subjects reported high risk sexual behavior: 17% reported commercial sex exchange, and 22% reported inconsistent condom use with multiple sexual partners during the prior 2 months. Conclusion: Based on prevalence in Boston, MA, universal screening for STI in substance abuse treatments programs is not warranted. However, routine screening for younger substance abusers and in communities with high prevalence should be considered.

Original languageEnglish (US)
Pages (from-to)93-99
Number of pages7
JournalDrug and Alcohol Dependence
Volume70
Issue number1
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Detoxification
Chlamydia
Sexually Transmitted Diseases
Substance-Related Disorders
Screening
Gonorrhea
Sexual Partners
Methadone
Ligase Chain Reaction
Neisseria gonorrhoeae
Chlamydia trachomatis
Sex Offenses
Condoms
Ligases
Risk-Taking
Sexual Behavior
Therapeutics
Urine
Testing

Keywords

  • Chlamydia
  • Detoxification
  • Drug treatment
  • Gonorrhea
  • Methadone
  • Sexually transmitted infection

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Liebschutz, J. M., Finley Garcia, E., Braslins, P. G., Christiansen, D., Horton, N. J., & Samet, J. H. (2003). Screening for sexually transmitted infections in substance abuse treatment programs. Drug and Alcohol Dependence, 70(1), 93-99. https://doi.org/10.1016/S0376-8716(02)00361-7

Screening for sexually transmitted infections in substance abuse treatment programs. / Liebschutz, Jane M.; Finley Garcia, Erin; Braslins, Phillip G.; Christiansen, Demian; Horton, Nicholas J.; Samet, Jeffrey H.

In: Drug and Alcohol Dependence, Vol. 70, No. 1, 01.05.2003, p. 93-99.

Research output: Contribution to journalArticle

Liebschutz, JM, Finley Garcia, E, Braslins, PG, Christiansen, D, Horton, NJ & Samet, JH 2003, 'Screening for sexually transmitted infections in substance abuse treatment programs', Drug and Alcohol Dependence, vol. 70, no. 1, pp. 93-99. https://doi.org/10.1016/S0376-8716(02)00361-7
Liebschutz JM, Finley Garcia E, Braslins PG, Christiansen D, Horton NJ, Samet JH. Screening for sexually transmitted infections in substance abuse treatment programs. Drug and Alcohol Dependence. 2003 May 1;70(1):93-99. https://doi.org/10.1016/S0376-8716(02)00361-7
Liebschutz, Jane M. ; Finley Garcia, Erin ; Braslins, Phillip G. ; Christiansen, Demian ; Horton, Nicholas J. ; Samet, Jeffrey H. / Screening for sexually transmitted infections in substance abuse treatment programs. In: Drug and Alcohol Dependence. 2003 ; Vol. 70, No. 1. pp. 93-99.
@article{878e8eeea9be41a4bd89f5506e8e048e,
title = "Screening for sexually transmitted infections in substance abuse treatment programs",
abstract = "Objectives: We evaluated the prevalence of the sexually transmitted infections (STIs) chlamydia and gonorrhea in clients at a methadone maintenance program and a residential detoxification program. Methods: We collected urine specimens for chlamydia and gonorrhea ligase chain reaction testing and assessed sexual, substance abuse and STI histories. Results: Of 700 subject assessments, 490 occurred among detoxification clients and 210 in methadone maintenance. Chlamydia trachomatis was detected in 5/700 (0.9, 95{\%} CI=0.1-1.8{\%}) and Neisseria gonorrhoeae in none. All chlamydia infected subjects were recruited from the detoxification program. Subjects reported high risk sexual behavior: 17{\%} reported commercial sex exchange, and 22{\%} reported inconsistent condom use with multiple sexual partners during the prior 2 months. Conclusion: Based on prevalence in Boston, MA, universal screening for STI in substance abuse treatments programs is not warranted. However, routine screening for younger substance abusers and in communities with high prevalence should be considered.",
keywords = "Chlamydia, Detoxification, Drug treatment, Gonorrhea, Methadone, Sexually transmitted infection",
author = "Liebschutz, {Jane M.} and {Finley Garcia}, Erin and Braslins, {Phillip G.} and Demian Christiansen and Horton, {Nicholas J.} and Samet, {Jeffrey H.}",
year = "2003",
month = "5",
day = "1",
doi = "10.1016/S0376-8716(02)00361-7",
language = "English (US)",
volume = "70",
pages = "93--99",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Screening for sexually transmitted infections in substance abuse treatment programs

AU - Liebschutz, Jane M.

AU - Finley Garcia, Erin

AU - Braslins, Phillip G.

AU - Christiansen, Demian

AU - Horton, Nicholas J.

AU - Samet, Jeffrey H.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Objectives: We evaluated the prevalence of the sexually transmitted infections (STIs) chlamydia and gonorrhea in clients at a methadone maintenance program and a residential detoxification program. Methods: We collected urine specimens for chlamydia and gonorrhea ligase chain reaction testing and assessed sexual, substance abuse and STI histories. Results: Of 700 subject assessments, 490 occurred among detoxification clients and 210 in methadone maintenance. Chlamydia trachomatis was detected in 5/700 (0.9, 95% CI=0.1-1.8%) and Neisseria gonorrhoeae in none. All chlamydia infected subjects were recruited from the detoxification program. Subjects reported high risk sexual behavior: 17% reported commercial sex exchange, and 22% reported inconsistent condom use with multiple sexual partners during the prior 2 months. Conclusion: Based on prevalence in Boston, MA, universal screening for STI in substance abuse treatments programs is not warranted. However, routine screening for younger substance abusers and in communities with high prevalence should be considered.

AB - Objectives: We evaluated the prevalence of the sexually transmitted infections (STIs) chlamydia and gonorrhea in clients at a methadone maintenance program and a residential detoxification program. Methods: We collected urine specimens for chlamydia and gonorrhea ligase chain reaction testing and assessed sexual, substance abuse and STI histories. Results: Of 700 subject assessments, 490 occurred among detoxification clients and 210 in methadone maintenance. Chlamydia trachomatis was detected in 5/700 (0.9, 95% CI=0.1-1.8%) and Neisseria gonorrhoeae in none. All chlamydia infected subjects were recruited from the detoxification program. Subjects reported high risk sexual behavior: 17% reported commercial sex exchange, and 22% reported inconsistent condom use with multiple sexual partners during the prior 2 months. Conclusion: Based on prevalence in Boston, MA, universal screening for STI in substance abuse treatments programs is not warranted. However, routine screening for younger substance abusers and in communities with high prevalence should be considered.

KW - Chlamydia

KW - Detoxification

KW - Drug treatment

KW - Gonorrhea

KW - Methadone

KW - Sexually transmitted infection

UR - http://www.scopus.com/inward/record.url?scp=0037401777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037401777&partnerID=8YFLogxK

U2 - 10.1016/S0376-8716(02)00361-7

DO - 10.1016/S0376-8716(02)00361-7

M3 - Article

C2 - 12681529

AN - SCOPUS:0037401777

VL - 70

SP - 93

EP - 99

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1

ER -